Monarch Bioimplants

Developer of bioimplant for peripheral nerve repair

placeRoot, Lucerne, Switzerland calendar_todayFounded 2016 language monarchbioimplants.com

Innovation

2 patent families (2 granted) — focus: Human necessities; filing pace accelerating. Cited 32 times.

YearFilings
20181
20201
20221
20251
20261

Investor mix

2 investors on record; lead investors include Global Emerging Markets, FastTrack Ventures.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon